Maternal diet’s effects on liver disease in offspring
More than half of people who become pregnant are overweight or obese at the time of conception, and obesity during pregnancy is associated with progeny who develop metabolic syndrome later in life.
Studies of humans and mammalian animal models have shown, for example, that high-fat diets during pregnancy and while nursing result in offspring more likely to develop nonalcoholic fatty liver disease and to have altered bile acid homeostasis.
Scientists at the Washington University School of Medicine in St. Louis recently undertook a study to learn more about how maternal obesity might influence the development of cholestasis, a liver disease for which therapies are limited.
In cholestasis, bile cannot reach the duodenum, the first portion of the small intestine, where it is supposed to facilitate food digestion. The disease can be brought on by several factors, including duct obstructions or narrowing, toxic compounds, infection and inflammation, disturbance of intestinal microbiota, and genetic abnormalities.
In their study, published in the Journal of Lipid Research, Michael D. Thompson and collaborators at Washington University fed female mice conventional chow or a high-fat, high-sucrose diet and bred them with lean males.
They fed the offspring DDC, which is short for 3,5-diethoxycarbonyl-1,4-dihydrocollidine, for two weeks to induce cholestasis. After this feeding period, the offspring ate conventional chow for 10 more days. They found that offspring from females on the high-fat, high-sucrose diet had increased fine branching of the bile duct and enhanced fibrotic response to DDC treatment and delayed recovery times from it.
Earlier this year, the team reported changes to offspring microbiome after maternal consumption of high-fat, high-sucrose chow, so they decided to feed antibiotic-treated mice cecal contents from the offspring that had been fed conventional chow or high-fat, high-sucrose, followed by DDC for two weeks. They found that cholestatic liver injury is transmissible in these mice models, further supporting the role of the microbiome in this disease.
For those reasons and others, a lot of research has been done and continues to this day on the effects of maternal diet on offspring.

Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.